Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04330664
Title Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mirati Therapeutics Inc.
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Jonsson Comprehensive Cancer Center Los Angeles California 90095 United States Details
UC Irvine Health Orange California 92868 United States Details
Northwestern Chicago Illinois 60611 United States Details
Cancer Center of Kansas Wichita Kansas 67214 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Boston Massachusetts 02215 United States Details
Henry Ford Detroit Michigan 48202 United States Details
Washington University School of Medicine Siteman Cancer Center Saint Louis Missouri 63110 United States Details
NYU Perlmutter Cancer Center New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10021 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
Froedtert Hospital & Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from for the field